Corporate Partners -
(Listed alphabetically)
GlaxoSmithKline (GSK) has a challenging and inspiring mission: to improve the quality of human life by enabling people to do more, feel better and live longer. This mission gives us the purpose to develop innovative medicines and products that help millions of people around the world.
As a company with a firm foundation in science, we have a flair for research and a track record of turning that research into innovative and effective drugs. Every hour we spend more than €350,000 to find new medicines. This includes screening about 65 million compounds each year in our search for new medicines.
We produce medicines across many disease areas - asthma, virus control, infectious disease, mental health, diabetes and digestive conditions. In addition, we are a leader in the important area of vaccines and are developing new treatments for cancer. For further information, please see our website www.gsk.com.
In Ireland, we work with a wide range of patient groups, in a variety of different disease areas such as asthma, cancer, diabetes, and HIV/AIDS. Our interest in patient advocacy is about understanding patient needs and their illness. Our aim is to support the voice of patients and to foster a constructive healthcare debate for all stakeholders. GSK and patient groups share a vision to improve patients’ access to effective treatments and services.
In 2009, GSK, through our Allen & Hanburys team, provided the Asthma Society of Ireland with a grant totalling €10,000 to support the Society’s general activities.
Allen & Hanburys' funding represented approximately 0.75%% of the overall income of the Asthma Society of Ireland in 2009.

Despite significant advances in healthcare in recent decades, many diseases are still under-diagnosed or not well treated, or there is not yet an effective therapy. Continued innovation is required to address these unmet medical needs. At the same time, the growing demand for healthcare, driven by people living longer, increasing populations and the emergence of new economies, means ever greater pressure on budgets.
AstraZeneca is a major international healthcare business engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of US$ 31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines.
At AstraZeneca, our challenge is to balance the associated pressure on the price of medicines with the cost of the continued innovation that brings benefit for patients and society. Innovative medicines also bring economic as well as therapeutic benefit to patients, helping to contribute to the communities in which we operate.
It is for this reason that AstraZeneca during 2008 donated grants of €20,400 to assist the Asthma Society in their quest for improvements for Asthma patients in Ireland.
During 2006, support
was given to the Asthma Society for their 'Asthma Schools
Project'. This project involved the largest 'attitudes
to asthma in schools' questionnaire ever to be carried
out to date in Ireland. As a result of this, a booklet
was written and produced to support the needs of those
looking after children with asthma in the educational setting.
To date, this has been one of the most requested items
the Asthma Society has developed.
In 2007 AstraZeneca and
the Asthma Society worked together on the Boston Marathon
project where 5 people with asthma competed in the Boston
Marathon, U.S.A
For more information on the collaborative work between AstraZeneca
and the Asthma Society please contact the Asthma Society
of Ireland.

In 2006, Dyson and the Asthma Society
of Ireland joined forces as research partners to tackle
the growing problem of asthma in Ireland and to increase
awareness about asthma and allergies whilst raising funds
for the organisation.
To launch the partnership the Asthma
Society of Ireland, in conjunction with its research partner
Dyson carried out a number of activities which included
a series of Asthma information days. This initiative was
introduced to help address the problem of Asthma in Ireland.
Asthma Clinics were set-up around the country in leading
Dyson retail outlets to offer members of the public information
on Asthma. Qualified respiratory nurses were on hand to
answer questions about asthma, and learn more about how
to reduce the risk of allergens in the home. This proved
a huge success country wide.
In addition to the Asthma Clinics, the
Asthma Society of Ireland also launched the follow-up Irish
ISAAC Research Study (based on the International Study
of Asthma and Allergies in Childhood protocol) 2006-7.
The aim of this ISAAC study was to obtain ongoing knowledge
of the growing prevalence and seriousness of asthma and
allergies in children in Ireland. The ASI carried out this
study in over 35 of secondary schools throughout the Republic
of Ireland in a similar fashion to that of previous studies.
In addition, dust samples from the school classrooms were
analysed for allergens such as house dust mites and moulds.
The study, partly funded by Dyson through a series of joint
promotions with the Asthma Society, gained insight into
the role of allergen exposure in the school environment,
where children spend between 25-30% of their day. Dyson
provided access to their research facilities and scientific
expertise to analyse the dust for allergens which was conducted
in the Dyson micro-biology lab at the Dyson HQ in Malmesbury,
Wiltshire.
In 2007 Dyson and the Asthma Society
of Ireland (ASI) stepped up their campaign to tackle the
problem of asthma in Ireland. Together, Dyson and the ASI,
designed a campaign to further raise awareness of asthma
and allergies in Ireland whilst raising funds for research.
Dyson introduced the Dyson
DC19 Allergy model which helps to remove pollen and dust
mites - some of the main causes of allergies in the home.
Dyson also gave a free Home Cleaning Kit* to every one
who bought the new model over the promotional period. Such
is Dyson's commitment to the ASI, the machine helped to
raise funds, by donating €10 to the charity for
every one sold.
Dyson's patented cyclone technology means
the DC19 Allergy retains even the finest dust particles.
A HEPA filter with bacteria killing screen traps bacteria
and mould is stopped dead in its tracks. The DC19 Allergy
also comes with a Flat OutTM tool that's thin enough to
fit under low furniture. So it's easier to reach under
sofas and beds to get rid of those fluffballs and the allergy
sufferer's arch enemy; the dust mite.
This year Dyson and the ASI will once
again run a campaign that will engage the consumer and
increase awareness of Asthma in Ireland. Proceeds from
every Dyson DC19 Allergy and DC20 Stowaway Allergy sold
will be donated to the Asthma Society of Ireland. This
promotion will commence on World Asthma Day (6th May 2008)
and run until the end of the month In conjunction with
this Dyson will for the first time be sponsoring the national
pollen count from May to July 2008.The irishhealth.com
pollen and airborne allergen forecasts use data provided
by the UK National Pollen and Aerobiology Research Unit's
network. These forecasts can assist people who suffer from
asthma and allergic rhinitis to plan their activities.
The forecasting service provides an index of the risk of
being affected by airborne allergic pollens. Go
to website.
Check our Latest
News Section for your chance to Win a Dyson Vacuum Cleaner!

Merck Sharp & Dohme Ireland (Human Health) Ltd. is committed to partnering with third party groups such as the Asthma Society of Ireland to achieve common goals such as providing balanced information, advice and support for patients. The company's support to the ASI has delivered some extremely successful and innovative campaigns over the last few years.
In 2008 MSD provided an unrestricted educational grant to support research initiatives and attendance at an international conference.
www.allergyandasthma.ie
One of Ireland's oldest companies, Malones produce a wide range of cleaning products made with natural ingredients.
Traditionally known for their scented, lavender wax polishes, the range now includes Malones Natural Wooden Floor Cleaners, with essential oils of Lavender, for all types of wooden floors and surfaces. Malones Natural Antibacterial Household Cleaner, a gentle all purpose cleaner for use all around the home and Malones new Leather Care polish spray , a natural, first to market alternative to aerosol polish. Lavender scented with soothing essential oils it is ideal for leather furniture, as well as leather shoes and bags.
Malones products are gentle and effective and being kinder to the environment may be more suitable for people with asthma and the many people who are sensitive to harsh cleaning products.
For more information go to www.malonesofdublin.ie

In 2008 Novartis supported the work
of the Asthma Society with an unrestricted educational
grant of €20,000.
|